Spinoff Transaction Considerations For Biotech M&A
By Andrew Goodman, Daniel Nicholas and Seo Salimi · June 27, 2025, 2:16 PM EDT
The biotech mergers and acquisitions market currently faces significant headwinds,[1] with challenges including frozen capital markets, regulatory uncertainty at the U.S. Food and Drug Administration and U.S. Department of Health and...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login